TNFRSF1A and neoplasm: Anti-TNFR1 alone substantially reduced tumor growth compared to control (Figure 6B), which correlated positively with an increased percentage of intratumor DCs (Figures S6A and S6C, left panel) and number (Figure 6C, right panel).